Moleculin Announces Additional Annamycin Patent Allowances to Enhance Global Exclusivity
Go back to Moleculin Announces Additional Annamycin Patent Allowances to Enhance Global Exclusivity| METABASIS THERAPEUT (NASDAQ: MBRX) | Delayed: 0.68 -0.01 (1.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.69 | 52 Week High | $9.58 | |||
| Open | $0.70 | 52 Week Low | $2.34 | |||
| Day High | $0.73 | P/E | N/A | |||
| Day Low | $0.65 | EPS | $-0.34 | |||
| Volume | 433,135 | |||||
